http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021230286-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67dd1f39f37bac4617e37d6d5c60aa8b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3231 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-712 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7115 |
| filingDate | 2021-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0eda25eaced0f48651ed5baebdcaf59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c6d2c6a3c6ab7103e43ef7cf5e8f248 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b2131091d7d097a683ded9cb492df66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bba1dbfaf44d3fa418588e5bb163273d |
| publicationDate | 2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021230286-A1 |
| titleOfInvention | Compound, method and pharmaceutical composition for regulating expression of ataxin 3 |
| abstract | A modified oligonucleotide that has an activity of inhibiting the expression of Ataxin 3 and has any of the following nucleic acid base sequences or a nucleic acid base sequence having 17 consecutive bases contained in the nucleic acid base sequences. 1) TCGGGTAAGTAGATTTTC (SEQ ID NO. 239), 2) GAAGTATCTGTAGGCCTA (SEQ ID NO. 240), 3) GGACTGTATAGGAGATTA (SEQ ID NO. 241), 4) GGTTATAGGATGCAGGTA (SEQ ID NO.242), 5) AGGTTATAGGATGCAGGT (SEQ ID NO.243), 6) GAAGCTAAGTAGGTGACT (SEQ ID NO. 244), 7) TGAAGCTAAGTAGGTGAC (SEQ ID NO. 245), 8) CCTAGTCACTTTGATAGA (SEQ ID NO. 246), 9) GGAACATCTTGAGTAGGT (SEQ ID NO. 247), 10) GGTGTTCAGGGTAGATGT (SEQ ID NO. 248), 11) GGATACTCTGCCCTGTTC (SEQ ID NO. 249), 12) GGTGTCAAACGTGTGGTT (SEQ ID NO. 250), 13) CCGTGTGCTAGTATTTGT (SEQ ID NO. 251), 14) TAGTAGAGTTTTGCTTGG (SEQ ID NO.252), 15) GATGTAGTAGAGTTTTGC (SEQ ID NO. 253), 16) TGATGTAGTAGAGTTTTG (SEQ ID NO. 254), 17) CTGATGTAGTAGAGTTTT (SEQ ID NO. 255), 19)GCAAGTTGGTTTGTGGTA (SEQ ID NO. 256), 20) TCTAGGCAATTGTGGTGG (SEQ ID NO. 257), 21) GTAACTCTGCACTTCCCA (SEQ ID NO. 258), 22) GTCATCCCTATGTCTTAT (SEQ ID NO. 259), 23) GTCATATGGTCAGGGTAT (SEQ ID NO. 260), 24) TGTCATATGGTCAGGGTA (SEQ ID NO. 261), 25) ATGTCATATGGTCAGGGT (SEQ ID NO. 262) and 26) TATGTCATATGGTCAGGG (SEQ ID NO. 263). |
| priorityDate | 2020-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.